During the past decade, York Hospital's Oncology Treatment Center conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 11 clinical trials were completed, i.e. on average, 1100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "York Hospital's Oncology Treatment Center" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 5 trials, followed by "NSABP Foundation Inc" with 3 trials sponsored, "Eastern Cooperative Oncology Group" with 2 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 1 trials sponsored and "Jeffrey Zwicker, MD" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "York Hospital's Oncology Treatment Center" #1 collaborator was "National Cancer Institute (NCI)" with 12 trials as a collaborator, "NCIC Clinical Trials Group" with 2 trials as a collaborator, "SWOG Cancer Research Network" with 2 trials as a collaborator, "Aptuit" with 1 trials as a collaborator and "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "York Hospital's Oncology Treatment Center" are "Breast Cancer" (6 trials), "Colorectal Cancer" (2 trials), "Lung Cancer" (2 trials), "Cancer Survivor" (1 trials) and "Chemotherapeutic Agent Toxicity" (1 trials). Many other conditions were trialed in "York Hospital's Oncology Treatment Center" in a lesser frequency.

Most popular intervention types in "York Hospital's Oncology Treatment Center" are "Drug" (9 trials), "Other" (8 trials), "Biological" (3 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (4 trials), "Placebo" (2 trials), "bevacizumab" (2 trials), "FOLFIRI" (1 trials) and "FOLFOX or" (1 trials). Other intervention names were less common.

The vast majority of trials in "York Hospital's Oncology Treatment Center" are 7 trials for "Female" genders, 6 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "York Hospital's Oncology Treatment Center". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in York Hospital's Oncology Treatment Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in York Hospital's Oncology Treatment Center, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".